Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 February 2023 | Story Edzani Nephalela | Photo Edzani Nephalela
Dr Luyanda Marhaya
Dr Luyanda Marhaya, Director of Academic Planning and Quality Assurance at the UFS.

Dr Luyanda Marhaya, Director of Academic Planning and Quality Assurance at the University of the Free State (UFS), has been selected by the Department of Higher Education and Training (DHET) to join the Foundation Provision Reference Group (FPRG). His primary role in this position is to assist the Department in assessing applications for foundation programmes submitted by universities, ensuring compliance with the current Foundation Provision Guidelines. 

As the author of the book Does Extended Programme Provision Work in South Africa?, Dr Marhaya is a recognised expert in the field. 

The Department of Communication and Marketing (DCM) at the UFS recently interviewed Dr Marhaya to understand his responsibilities better:

Can you tell us more about your appointment as a member of the FPRG?

Over and above the supportive role, one of the major issues I will be involved in will be to provide input into the revision and finalisation of the Extended Curriculum Programme Policy Framework for the higher sector in South Africa.

What kind of projects or initiatives do you see being a priority?

One of the significant ongoing projects will be evaluating applications for foundation programmes of the different universities in South Africa, so one will have to allocate time, as many universities currently offer these programmes.

What do you hope to bring to the table as a group member?

Interestingly, I started as an academic about 15 years ago in the foundation programmes. I spent a good five years of my teaching at a university level dealing with students who gained entry through foundation programmes. I completely understand their purpose, intentions, and significance, especially concerning student access and success. 

How will the Foundation Provision Reference Group benefit students and the education system?

Student access is a serious issue in South Africa, especially regarding the preparedness of many university students. So, I believe if we develop guidelines that can assist universities in coordinating these programmes in a well-structured manner, there could be many benefits.

What challenges do you anticipate facing in this role, and how do you plan to address them?

I think the major issue will be time constraints. My role is very demanding, and I am already involved in several other external committees, such as the Council on Higher Education, so I think my time management has to be very good.

How do you plan to work with other group members to achieve the group’s goals?

I believe in lifelong learning. I will certainly contribute, but the value of these interactions comes from learning from others.

Can you discuss any past experiences that have prepared you for this role?

I also wrote a book, titled Does Extended Programme Provision Work in South Africa?, in which I explored all the intricacies around these programmes. As Director: Academic Planning at the UFS, I also oversee the quality and provision of foundation programmes, so you could say I bring some expertise.

What are your long-term goals for the foundation programmes, and your role as a reference group member?

I foresee this as a long-term service that will benefit the country as a whole, so I suppose the Department will keep up so that we can provide capacity development to all universities that offer foundation programmes.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept